As with other drugs, Revlimid can cause side effects, such as skin rash and constipation. Revlimid (lenalidomide) is approved by the Food and Drug Administration (FDA) to treat the following ...

such as a mild rash, call your doctor right away. They may suggest a treatment to manage your symptoms and can determine whether you should keep taking Revlimid. If you have symptoms of a severe ...

Celgene's big-selling blood cancer drug Revlimid may cause a rare but potentially fatal skin reaction in some patients ... and discontinue the drug if a rash appears. According to the company ...

Health-Related Quality of Life Analysis An additional ... REVLIMID interruption or discontinuation should be considered for Grade 2-3 skin rash. REVLIMID must be discontinued for angioedema ...

Revlimid interruption or discontinuation should be considered for Grade 2-3 skin rash. It must be discontinued for angioedema ... or other Grade 3 or 4 toxicity judged to be related to Revlimid. For ...

Adverse events reported in ≥15% of del 5q MDS patients (REVLIMID): thrombocytopenia (61.5%), neutropenia (58.8%), diarrhea (49%), pruritus (42%), rash (36 ... the full SMPC related to the EC ...

The Food and Drug Administration (FDA) has approved Sarclisa (isatuximab-irfc) with Velcade (bortezomib), Revlimid (lenalidomide ... peripheral edema, rash, infusion-related reaction, insomnia and ...